LivaNova Announces Vladimir Makatsaria as New CEO

2mon ago, source: TipRanks on MSN

LivaNova PLC (LIVN) has released an update to notify the public and investors about its officers. LivaNova PLC has appointed ...

LivaNova Plc (NASDAQ: LIVN)

21d ago, source: The Motley Fool

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare ...

LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029

1mon ago, source: Stockhouse

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced the pricing of $300 million aggregate principal amount of 2.50% convertible senior notes due 2029 (the ...

Shareholders in LivaNova (NASDAQ:LIVN) have lost 34%, as stock drops 3.1% this past week

3d ago, source:

For many investors, the main point of stock picking is to generate higher returns than the overall market. But ...

Has LivaNova PLC's (NASDAQ:LIVN) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

1mon ago, source: Yahoo Finance

LivaNova's (NASDAQ:LIVN) stock is up by a considerable 27% over the past three months. Given that stock prices are usually aligned with a company's financial performance in the long-term, we ...

LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes

1mon ago, source: Stockhouse

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its intention to offer $300 million aggregate principal amount of convertible senior notes due 2029 (the ...

LivaNova PLC LIA

14d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea

1mon ago, source: Yahoo Finance

LONDON, March 20, 2024--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its OSPREY clinical study, Treating Obstructive Sleep Apnea Using ...

LivaNova to Announce First-Quarter 2024 Results

28d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

LivaNova to Announce Third-Quarter 2023 Results

9d ago, source: ADVFN

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its third-quarter 2023 results on Wednesday, November 1, 2023 at 12 p.m. London ...

LivaNova PLC

28d ago, source: U.S. News & World Report

Analysts say these cheap stocks have plenty of upside.

LivaNova PLC

1mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...